Understanding Human Behavior To Help Improve Patient Adherence
BEAMER is delighted to announce that its project lead Claire Everitt, the Device Design and [...]
Read More
29
Nov
Nov
BEAMER Gains Positive Reception within the Dutch CRO Community
Recently, Sjaak Bloem and I had the privilege of presenting the BEAMER project to the [...]
Read More
29
Nov
Nov
BEAMER Meeting in Thessaloniki Sets Vision for Future Healthcare Solutions
It has become a tradition within BEAMER to gather during the autumn months for a [...]
Read More
02
Nov
Nov
BEAMER’s Innovative Research on AI-Driven Treatment Adherence Prediction Recognised at International Conference
In a remarkable showcase of cutting-edge research and innovation, Beatriz Merino from BEAMER’s Work Package [...]
Read More
07
Aug
Aug
BEAMER awarded as the best research project at the semFYC Conference 2023
The 43rd edition of the Spanish Society of Family and Community Medicine (semFYC) Conference was [...]
Read More
04
Jul
Jul
BEAMER Project Members Make Further Advances in Copenhagen, Denmark
This past month, partners from the BEAMER project gathered in the coastal city of Copenhagen, [...]
Read More
07
Feb
Feb
Where Dialogue Meets Actions: The BEAMER Consortium Gathering in Portugal
Not much time has passed since the entire BEAMER consortium came together in Porto (Portugal) [...]
Read More
10
Nov
Nov
Supported by a grant from IMI, the project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101034369. This joint undertaking receives support from the European Union’s Horizon 2020 research and innovation programme, the European Federation of Pharmaceutical Industries and Associations [EFPIA] and Link2Trials. The total budget is 11.9 M€ for a project duration of 60 months.
Disclaimer:
Information on this website reflects project owner’s views and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained therein.
